AlphAIAlphAI — Financial news for AI agents
investing.com$PRVA

Privia Health Group earnings beat by $0.12, revenue topped estimates

Privia Health Group (PRVA) reported Q3 EPS of $0.21, beating estimates by $0.12, with revenue at $656.96M, exceeding expectations. The company guided FY 2026 revenue to $2.50B-$2.55B, above consensus. PRVA's stock is down 0.22% over 3 months and 6.59% over 12 months. InvestingPro rates its financial health as 'great performance'.

Original reporting
investing.com
Published Nov 5, 2026, 1:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 1:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$PRVA
Bullish
high confidence
Mentioned
$PRVA
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PRVABullishMed
01

Why it matters

The earnings beat provides a fresh catalyst that could attract short‑term buying interest, but guidance remains near consensus, limiting upside.

02

Market read

Earnings surprise may generate modest price movement in PRVA and modest sentiment lift for similar health‑tech stocks.

03

What to watch

Guidance remains modest; investors may focus on FY2026 revenue range rather than the beat.

Relevance 7/10Novelty 8/10Timing: post‑earnings today

Background

Privia Health Group is a provider of technology‑enabled outpatient services; its earnings release is part of the quarterly reporting cycle.

Company-level read

Ticker impact

$PRVABullishHigh confidence
Context

Privia Health Group reported Q3 EPS of $0.21, beating estimates by $0.12 and revenue of $656.96M above consensus.

Expected impact

likely modest upside as the market prices in the earnings beat

Evidence & confidence

The surprise EPS and revenue beat are fresh data; traders may buy on the positive surprise.

Market effects

Sector

Positive earnings may lift other health‑tech and revenue‑cycle stocks.

Regional

U.S. market may see a small boost in the healthcare services sector.

Global

Limited to U.S. investors; no broader macro effect.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face profit‑taking pressure.

Key entities

  • company
    Privia Health Group

    NASDAQ‑listed health‑tech services provider.

Read at source← All news

StoryPrivia Health reports Q3 2026 results, raises full‑year outlook and announces $36 million acquisition

Also covered by

5 outlets

Related articles

$PRVAHigh

Privia (PRVA) Q3 2026 Earnings Call Transcript

Privia (PRVA) raised its 2026 outlook, expecting 6,000 clinicians by year-end, 23.9% EBITDA growth, and $2.91B in practice collections. It will exit a Montana partnership and acquire American Choice Healthcare for $36M, impacting 2027 metrics. Q3 results showed 12.2% year-over-year provider growth and 21.9% EBITDA increase.

finance.yahoo.com
$PRVAHighAI 8/10

Privia Health: Q3 Earnings Snapshot

Privia Health Group Inc. (PRVA) reported Q3 earnings of $13.5M, or 10 cents per share, beating estimates of 9 cents. Revenue was $657M, exceeding forecasts of $599.6M. The company expects full-year revenue between $2.35B and $2.45B.

finance.yahoo.com
$PRVAHigh

Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results

Privia Health Group, Inc. (PRVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Privia Health Reports Strong Third Quarter and Year-to-Date 2026 Results – YTD’26 Net Income of $25.6M, +85.9% from YTD’25 – YTD’26 Adjusted EBITDA of $114.7M, +21.9% from YTD’25 – Full-Year 2026 Guidance Raised to Above High End for All Key Financial Metrics – Expan

SEC EDGAR 8-K